Low GCS is a syndrome, not a diagnosis. The first bedside sequence is airway, oxygenation, GCS, glucose, exposure, ABG and ECG, while sepsis, CNS infection, seizure, metabolic disturbance and toxidrome remain active possibilities.

An in-flight seizure or hypoxia leaves limited equipment, patchy monitoring and a diversion decision. The practical move is early ground medical support, clear ABCs, a gathered kit station and deliberate use of nurses, paramedics or other clinicians on board.

Patients asking for multi-cancer blood tests need screening, diagnostic testing and hereditary surveillance kept separate. A negative result does not rule out cancer, while a positive signal can trigger anxiety, imaging and procedures, especially without tissue-of-origin information.

Postoperative surgical oncology is becoming part of vaccine trial work. Personalised mRNA approaches rely on tumour sequencing, neoantigen selection, tissue quality and rapid specimen processing, with ctDNA used to identify patients more likely to have occult residual disease.

ICU sustainability is framed as high-value care, not rationing. Deprescribing, enteral conversion, correct waste segregation, fewer unnecessary investigations and safe reuse of patient-specific items can reduce carbon impact while removing low-value treatment.

Pregnancy or breastfeeding after anti-CD20 treatment needs mechanism and timing documented, not just drug detectability. Placental transfer changes across gestation, breast milk transfer appears low, and exposed infants may need attention to B cell counts and vaccine responses.

Gender-affirming care is approached through critical appraisal of a flawed historical follow-up study. The teaching is to separate evidence quality from assumptions about social conformity, and to prioritise patient-reported distress, functioning and safety when services are discussed.